Source-grounded facts extracted from LivaNova PLC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
LivaNova PLC updated its FY2023 guidance (initiated).
“LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023.”
LivaNova PLC reported FY2022 results: revenue $1.02 billion, EPS $1.61.
“Full-year 2022 revenue of $1.02 billion decreased 1.3 percent on a reported basis and increased 2.9 percent on a constant-currency basis, as compared to the prior year • Full-year 2022 revenue, excluding revenue from the Heart Valve business which was divested effective June 1, 2021, increased 2.3 percent on a reported basis and 6.7 percent on a constant-currency basis, as compared to the prior year • Full-year 2022 U.S. GAAP diluted loss per share was $1.61 and adjusted diluted earnings per share was $2.39”
LivaNova PLC reported Q4 2022 results: revenue $274.9 million, EPS $0.03.
“Fourth-quarter revenue of $274.9 million increased 1.8 percent on a reported basis and 6.2 percent on a constant-currency basis, as compared to the prior-year period • Fourth-quarter U.S. GAAP diluted earnings per share was $0.03 and adjusted diluted earnings per share was $0.81”
LivaNova PLC reported the quarter ended September 30, 2022 results: revenue $252.6 million, EPS $2.01. Guidance reaffirmed.
“Revenue of $252.6 million for the quarter decreased 0.2 percent on a reported basis and increased 5.2 percent on a constant-currency basis, as compared to the prior-year period • U.S. GAAP diluted loss per share was $2.01, including a non-cash goodwill impairment charge of approximately $2.40 per share, and adjusted diluted earnings per share was $0.58”
Brooke Story was appointed as Director at LivaNova PLC.
“On September 15, 2022, the Board of Directors (the “Board”) of LivaNova PLC (the “Company” or “LivaNova”) appointed Brooke Story to the Board.”
Keyna Skeffington departed as General Counsel and Corporate Secretary at LivaNova PLC.
“On June 13, 2022, LivaNova PLC (the “Company”) announced that Keyna Skeffington, General Counsel and Corporate Secretary, has announced her intent to retire.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.